<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04254523</url>
  </required_header>
  <id_info>
    <org_study_id>2020-4832</org_study_id>
    <nct_id>NCT04254523</nct_id>
  </id_info>
  <brief_title>Programmed Intermittent Bolus Versus Continuous Infusion for Epidural Analgesia in Abdominal Surgery</brief_title>
  <official_title>Programmed Intermittent Bolus Versus Continuous Infusion for Epidural Analgesia in Major Abdominal Surgery: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidural analgesia is an efficient way to relieve pain after major abdominal surgery. Two
      different protocols are used to provide analgesia: continuous epidural infusion (CEI) and
      programmed intermittent boluses (PIEB). CEI consists in the delivery of a continuous
      administration of the intended hourly dose. PIEB consists in the administration of sequential
      high pressure boluses of the intended dose. Although some studies in the postoperative
      setting have observed that PIEB reduces the total dose needed to ensure adequate pain
      control, the clinical value of this finding is still uncertain. Moreover, nursing and medical
      interventions to the epidural infusion rates are frequently needed in the first 48
      postoperative hours to optimize the provision of analgesia. These interventions add to the
      already important nursing workload associated with major abdominal surgery, and are
      correlated with suboptimal analgesia for the patient.

      This randomized controlled trial aims to compare the effect of epidural PIEB on the workload
      as a reflection of adequate analgesia compared to the standard CEI protocol in use. The
      investigators hypothesize that the use of PIEB decreases the number of interventions needed
      to obtain adequate analgesia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single (participant)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of epidural infusion adjustments</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Number of epidural infusion adjustments by the nursing team (based on the usual protocol of our institution) will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of analgesia</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Pain is measured using the numeric rating scale (NRS : 0-10, 10 being the worst possible pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional analgesia</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Prescribed additional analgesia (IV/PO/S/C opioids or other) administered to the patient while epidural analgesia is still provided.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Documented by medical records review (vitals, medication received, temporary interruption of the local anesthetic epidural infusion, IV fluids, etc.).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor use</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>The use of vasopressor is documented by review of the medical records.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total epidural dose of local anesthetic administered</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Total epidural dose of local anesthetic administered (including additional boluses ordered by the anesthesiologist and PCEA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total epidural dose of opioid administered</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Total epidural dose of opioid administered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patient-controlled epidural analgesia (PCEA) administered/refused</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Number of PCEA administered/refused.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>From the admission to the ICU until the end of the ICU stay (or until the patient has met ICU discharge criteria).</time_frame>
    <description>ICU length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to postoperative mobilization</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Time to postoperative mobilization as defined as a patient who can tolerate standing without symptoms that limit the mobilization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Nausea and vomiting</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Pruritus</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Pruritus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor blockade</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Bromage score is used to monitor motor blockade.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of epidural removal</measure>
    <time_frame>48 hours after reaching the discharge criteria from the post-anesthesia care unit (or until the beginning of the epidural weaning period, if started in less than 48 hours)</time_frame>
    <description>Incidence of epidural catheter intentionally or unintentionally withdrawn.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Analgesia, Epidural</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Programmed intermittent epidural bolus (PIEB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Programmed intermittent epidural boluses of bupivacaine 0,1% are administered every hour.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous epidural infusion (CEI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A continuous epidural infusion of bupivacaine 0,1% is administered at a prescribed rate in milliliters per hour.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Programmed intermittent epidural bolus (PIEB) of bupicavaine</intervention_name>
    <description>Programmed intermittent epidural boluses of bupivacaine 0,1% are administered every hour. Protocolized adjustments of the dose are performed in order to obtain adequate analgesia. Standardized patient-controlled epidural boluses are available as top-ups.</description>
    <arm_group_label>Programmed intermittent epidural bolus (PIEB)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous epidural infusion (CEI) of bupivacaine</intervention_name>
    <description>A continuous epidural infusion of bupivacaine 0,1% is administered at a prescribed rate. Protocolized adjustments of the dose are performed in order to obtain adequate analgesia. Standardized patient-controlled epidural boluses are available as top-ups.</description>
    <arm_group_label>Continuous epidural infusion (CEI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous epidural infusion (CEI) of morphine</intervention_name>
    <description>A morphine infusion (0,1mg/ml) is administered in both groups at a prescribed rate. Protocolized adjustments of the dose are performed in order to obtain adequate analgesia.</description>
    <arm_group_label>Continuous epidural infusion (CEI)</arm_group_label>
    <arm_group_label>Programmed intermittent epidural bolus (PIEB)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (18 years and older)

          -  Major abdominal surgery in an elective setting

          -  Thoracic epidural (between T7 and T12)

        Exclusion Criteria:

          -  Contraindication to bupivacaine

          -  Contraindication to morphine

          -  Decision to keep the patient intubated and sedated at the end of the surgery

          -  Chronic opioid use (&gt; 3 months)

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esther Breton, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Qu√©bec-Universite Laval</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Myriam Boivin, MD</last_name>
    <phone>4185716970</phone>
    <email>myriam.boivin.1@ulaval.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rosalie Brochu, MD</last_name>
    <phone>4189258349</phone>
    <email>rosalie.brochu.1@ulaval.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Quebec-Universite Laval</name>
      <address>
        <city>Quebec</city>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esther Breton, MD, FRCPC</last_name>
      <phone>14189320162</phone>
      <email>estherbreton@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Esther Breton, MD, FRCPC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>February 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>February 2, 2020</last_update_submitted>
  <last_update_submitted_qc>February 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHU de Quebec-Universite Laval</investigator_affiliation>
    <investigator_full_name>Esther Breton</investigator_full_name>
    <investigator_title>Doctor Esther Breton, MD, FRCPC</investigator_title>
  </responsible_party>
  <keyword>Anesthesia, Epidural</keyword>
  <keyword>Postoperative Period</keyword>
  <keyword>Analgesia, Patient-Controlled</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

